From symptom relief to disease modifying allergy treatment with Glycan-Allergen Immunotherapy

Project Information

GAIT

Grant agreement ID: 761853

DOI 10.3030/761853

Closed project

EC signature date 4 February 2017

Start date 1 March 2017

End date 31 August 2017

Funded under

• INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies – Biotechnology

Total cost € 71 429,00

EU contribution € 50 000,00

Coordinated by

DC4U
Netherlands